Soligenix
SNGX
#11023
Rank
A$8.42 M
Marketcap
A$0.36
Share price
-5.06%
Change (1 day)
-82.27%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -A$17.47 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$17.8 Million a decrease over its 2024 earnings that were of -A$14.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.47 Million-1.88%
2025 -A$17.8 Million26.72%
2024 -A$14.05 Million22.96%
2023 -A$11.43 Million-45.74%
2022 -A$21.05 Million11.88%
2021 -A$18.82 Million-32.37%
2020 -A$27.82 Million83.18%
2019 -A$15.19 Million11.57%
2018 -A$13.62 Million19.29%
2017 -A$11.41 Million33%
2016 -A$8.58 Million-19.7%
2015 -A$10.69 Million5.16%
2014 -A$10.16 Million
2010 -A$11.47 Million26.12%
2009 -A$9.1 Million75.1%
2008 -A$5.2 Million-45.38%
2007 -A$9.51 Million-22.84%
2006 -A$12.32 Million66.15%
2005 -A$7.42 Million-16.65%
2004 -A$8.9 Million13.28%
2003 -A$7.86 Million-11.88%
2002 -A$8.92 Million-59.44%
2001 -A$21.98 Million378.18%
2000 -A$4.6 Million-38.53%
1999 -A$7.48 Million-18.43%
1998 -A$9.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.12 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.46 B-59,636.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.70 B-66,642.75%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$27.28 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$62.75 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.83 B-10,558.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$4.14 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.3 Billion 1,562.71%๐Ÿ‡บ๐Ÿ‡ธ USA